Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis

被引:0
|
作者
M. Kristen Demoruelle
Hong Wang
Ryan L. Davis
Ashley Visser
Johnny Hoang
Jill M. Norris
V. Michael Holers
Kevin D. Deane
Erika Darrah
机构
[1] University of Colorado Anschutz Medical Campus,Division of Rheumatology
[2] The Johns Hopkins University,Division of Rheumatology
[3] Colorado School of Public Health,undefined
来源
Arthritis Research & Therapy | / 23卷
关键词
Rheumatoid arthritis; Anti-PAD4 antibodies; Lung; Sputum; Saliva;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Peptidylarginine Deiminase 4 Contributes to Tumor Necrosis Factor α-Induced Inflammatory Arthritis
    Shelef, Miriam A.
    Sokolove, Jeremy
    Lahey, Lauren J.
    Wagner, Catriona A.
    Sackmann, Eric K.
    Warner, Thomas F.
    Wang, Yanming
    Beebe, David J.
    Robinson, William H.
    Huttenlocher, Anna
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (06) : 1482 - 1491
  • [22] Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
    Naoto Umeda
    Isao Matsumoto
    Hoshimi Kawaguchi
    Yuko Kurashima
    Yuya Kondo
    Hiroto Tsuboi
    Hiroshi Ogishima
    Takeshi Suzuki
    Yayoi Kagami
    Takuya Sakyu
    Akihito Ishigami
    Naoki Maruyama
    Takayuki Sumida
    Clinical Rheumatology, 2016, 35 : 1181 - 1188
  • [23] Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis
    Ren, Jiaqi
    Sun, Lin
    Zhao, Jinxia
    CLINICAL RHEUMATOLOGY, 2017, 36 (11) : 2431 - 2438
  • [24] Peptidylarginine Deiminase Type 4 and Methyl-CpG Binding Domain 4 Polymorphisms in Chinese Patients with Rheumatoid Arthritis
    Cheng, Jinluo
    Zhang, Hui
    Zhuang, Chao
    Liu, Ruiping
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (06) : 1159 - 1165
  • [25] Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis:: no influence of the presence of anti-citrullinated peptide antibodies
    Farago, B.
    Talian, G. C.
    Maasz, A.
    Magyari, L.
    Horvatovich, K.
    Kovacs, B.
    Cserep, V.
    Kisfali, P.
    Kiss, C. G.
    Czirjak, L.
    Melegh, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (04) : 523 - 528
  • [26] Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case–control study
    Berthold Hoppe
    Thomas Häupl
    Rudolf Gruber
    Holger Kiesewetter
    Gerd R Burmester
    Abdulgabar Salama
    Thomas Dörner
    Arthritis Research & Therapy, 8
  • [27] Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis
    Wang, Wei
    Li, Jinming
    CLINICAL RHEUMATOLOGY, 2011, 30 (04) : 563 - 567
  • [28] Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice
    Akari Suzuki
    Yuta Kochi
    Hirofumi Shoda
    Yu Seri
    Keishi Fujio
    Tetsuji Sawada
    Ryo Yamada
    Kazuhiko Yamamoto
    BMC Musculoskeletal Disorders, 17
  • [29] Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice
    Suzuki, Akari
    Kochi, Yuta
    Shoda, Hirofumi
    Seri, Yu
    Fujio, Keishi
    Sawada, Tetsuji
    Yamada, Ryo
    Yamamoto, Kazuhiko
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [30] Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis
    Wei Wang
    Jinming Li
    Clinical Rheumatology, 2011, 30 : 563 - 567